Market Snapshot:
Due to upsurging applications of 1, 4 Butanediol in manufacturing plastic, elastic, fibers, polyurethanes and many others will lead to stabilize the demand in the forecasted period. 1, 4 Butanediol is an organic colorless compound with 1 out of 4 stable isotopes of butanol. This chemical is also used as a solvent in glue removers and industrial cleaners such as tetrahydrofuran (THF). It is also used in manufacturing engineering plastics, fibers, medicines, cosmetics, and many others. In addition to this, it can be used in artificial leather, pesticide, hardener, solvent and rust remover as well.
Highlights from 1,4-Butanediol Market Study
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Forecast Value (2028) | USD 14.19 Million |
Unit | Value (USD Million) |
CAGR | 8.36% |
The key Vendors profiled in the report are BASF SE (Germany), Dairen Chemical Corporation (China), LyondellBasell Industries Holdings B.V. (United States), Ashland Inc. (United States), Nanya Plastics Corporation (Taiwan), Mitsubishi Chemical Corporation (Japan), INVISTA (United States), Meike Chemical (China), Xinjiang Tianye Co. Ltd. (China) and Changzhou Changcheng Energy Source Equipment Co Ltd. (China). Additionally, other players that are part of this comprehensive study are Shanxi Sanwei Group Co., Ltd. (China), Shaanxi Bidiou Chemical Industry Co Ltd (China), Sichuan Tianhua Company Limited (China), Henan Kaixiang Chemical Co., Ltd. (China) and Xinjiang Blueridge Tunhe Chemical Industry Co. Ltd. (China).
Geographic Breakdown and Segment Analysis
The Global 1,4-Butanediol market presents a comprehensive analysis of the 1,4-Butanediol market by end-user/application (Tetrahydrofuran (THF), Polybutylene Terephthalate (PBT), Gamma-Butyrolactone (GBL), Polyurethanes (PU) and Others), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global 1,4-Butanediol industry. Investors and Vendors can easily understand the inherent opportunities and challenges for their products in the geographical region of interest.
For instance, while the holds majority of market share of the 1,4-Butanediol market
Analyst at AMA have segmented the market study of Global 1,4-Butanediol market by Type, Application and Region. On the basis of Type, Reppe Process are dominating the market and hold 46.55% of market share in the year 2022 where as Davy process stood as second largest market share and accounted for 27.37%. On the basis of application, Tetrahydrofuran (THF) segment is dominating the market and hold 31.25% of market share where as Polybutylene Terephthalate (PBT) segment stood as second largest market.
1,4-Butanediol Market Dynamics:
Attributes | Details |
---|
Growth Drivers | - Upsurging Adoption of 1, 4 Butanediol in Tetrahydrofuran (THF) Industry
- Increasing Demand for Polybutylene Terephthalate will ultimately maximize the Butanediol Consumption
|
Influencing Trends | - Growing Demand for the Treatment of Intensive-Care Patients
- Introduction to 1, 4 Butanediol in Number of Polybutylene Terephthalate (PBT) Applications
|
Restraints | - UNSAFE for both Mother and Infant in Breast Feeding and Pregnancy
- Its byproduct, “GHB” can Slowdown the Heart Rate
|
Gaps & Opportunities | - Growing Instances of Blood Pressure Problems across the global Population
- Increasing Usage in Medications for Mental Conditions
|
The U.S. Drug Enforcement Agency reported that there were 189 seizures in 2011 (14.25038 kg, 18.3223 l) and 152 seizures in 2012 (3.763292 kg, 25.96455 l) 80. In the most recently accessed report from the European Monitoring Centre for Drugs and Drug Addiction of 2011, Finland reported two seizures of 1, 4-BD (228 ml) and Norway reported 1 seizure (0.07 l). No other countries were identified in this report that had seizures of 1, 4-butanediol.
Regulatory Insights:
FDA has been warning the public about a group of products sold as dietary supplements for bodybuilding, weight loss and sleep inducement which have been determined to pose a significant public health hazard. These products are chemically related to gamma-butyrolactone (GBL), gamma-hydroxybutyric acid (GHB), and 1, 4 butanediol (BD), and can cause dangerously low respiratory rates (intubation may be required), unconsciousness/coma, vomiting, seizures, bradycardia, and death. GBL, GHB, and BD have been linked to at least 122 serious illnesses reported to the FDA, including three deaths. These agents, which are powerful hypnotic substances known to produce significant and potentially dangerous sedative effects, also increase the effects of alcohol and are even more dangerous when consumed with other central nervous system depressant drugs.
14-Butanediols market companies operating in these industries are focusing more on efficient growth, improvement of operational efficiency, and productivity. The market is highly competitive with a few players occupying the major share. The key players are highly focused on developing and innovating new strategies to maintain their market position and customer base. The companies are coming up with partnerships or agreements along with planning strategic activities such as partnerships, product launches, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge.
Key Target Audience
Butanediol Manufacturers, Butanediol Distributors and Traders, Pharmaceutical Industry Associations, Healthcare Agencies, Non Profit Healthcare Organizations, Government Agencies, Research and Development Institutes and Others